The global respiratory inhaler market was valued at US$ 27,779.9 million in 2017, and is expected to register a CAGR of over 4%.
Market analysis by product type:
On the basis of product type segmentation, metered dose inhalers is expected to account for significantly higher revenue contribution
Market analysis by application:
Among all the application segments, chronic obstructive pulmonary disease segment is expected to register highest CAGR of over 4.5%
Market analysis by technology:
Among all the application segments, manual segment is expected to account for significantly higher revenue contribution
Market analysis by region:
North America market is expected to dominate the global respiratory inhaler market, and it accounts for largest market revenue over US$ 9,498.6million in 2017
Global Prefilled Syringes Market Competitive analysis:
AstraZeneca Plc, Beximco Pharmaceuticals Ltd, Boehringer Ingelheim GmbH, Cipla Ltd, GlaxoSmithKline Plc, Koninklijke Philips N.V, Merck & Co. Inc, Teva Pharmaceutical Industries Ltd, Omron Healthcare Europe B.V, PARI Medical Holding, H&T PRESSPART.
Infographic by Respiratory Inhaler Market